AGP Picks
View all

Cadaviz expands U.S. rollout across 10+ states

6 hours ago
Cadaviz expands U.S. rollout across 10+ states

By AI, Created 11:16 AM UTC, June 03, 2026, /AGP/ – Immersivevision Technology Inc. says it has launched Cadaviz, its virtual dissection table, across U.S. educational and healthcare institutions in more than 10 states. The company also says Cadaviz is now available through the TIPS Purchasing Coop, which could make procurement faster for schools and training centers.

Why it matters: - Cadaviz gives medical and anatomy programs a virtual alternative to cadaver-based dissection. - The TIPS Purchasing Coop listing could reduce procurement time for institutions that want to buy without a traditional RFP. - Immersivevision Technology is using the U.S. rollout to push deeper into North American education and healthcare training.

What happened: - Immersivevision Technology Inc. announced the full-scale commercial rollout of Cadaviz in the U.S. on June 3, 2026. - The rollout covers educational and healthcare institutions across the country. - The company says Cadaviz is already in use at schools, colleges and training centres in more than 10 states. - The states named in the release include Mississippi, Idaho, Florida, Massachusetts, Illinois, California, Texas and Iowa. - Immersivevision Technology Inc. was incorporated in the U.S. in 2025 as a wholly owned subsidiary of Immersivevision Technology Pvt. Ltd.

The details: - Cadaviz is described as a virtual dissection table built for anatomy and physiology learning. - The platform offers photorealistic 3D human anatomy with layered dissection across major body systems. - Cadaviz supports multi-user collaboration, allowing entire classrooms to dissect, annotate and explore at the same time. - The system is designed for pre-med, nursing, radiology, surgical training and allied health programs. - The company says Cadaviz removes cadaver procurement, storage and disposal logistics. - Immersivevision says Cadaviz has been deployed at institutions in 11 countries. - The release says the platform has shown measurable improvements in student outcomes. - Immersivevision says the global product line has delivered 80% year-over-year revenue growth. - The U.S. operation includes a U.S.-based field sales team, a North American distributor network and a rapid deployment program. - The company says institutions can go live in weeks rather than months. - The TIPS arrangement allows partner institutions to purchase Cadaviz directly through the coop and avoid the RFP process. - Steven King, president of Immersivevision Inc., said the TIPS availability allows partner institutions to buy the technology directly through the coop without dealing with an RFP process. - King also thanked the TIPS team for its support. - Immersivevision says it is working with simulation centers, medical schools, community colleges, high schools and healthcare training facilities across the U.S. - The company lists a demo request link here: Schedule a Demo - More information is available here: Learn more about Cadaviz in the U.S.

Between the lines: - The TIPS listing signals a procurement strategy built around speed and lower friction, which can matter in institutional buying cycles. - The rollout pairs product sales with a local U.S. operating structure, suggesting Immersivevision is moving from market entry to broader commercialization. - The release leans heavily on global deployment history and feature claims to position Cadaviz as the higher-end option in a competitive market.

What’s next: - Immersivevision says it will keep partnering with U.S. institutions that train future healthcare workers. - The company is inviting administrators, educators and procurement teams to schedule demos and evaluate Cadaviz for local deployment. - Continued expansion across more U.S. campuses appears to be the near-term goal of the rollout.

The bottom line: - Cadaviz is now being sold in the U.S. at scale, and Immersivevision is betting that procurement access plus virtual anatomy capabilities will accelerate adoption.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Educating America Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Sign up for:

Educating America Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.